Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Neomi Mativ"'
Autor:
Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Mahmoud Abu Amna, Anton Ouryvaev, Shiri Procaccia, Idan Cohen, Anca Leibovici, Luiza Akria, Dimitry Goncharov, Neomi Mativ, Avia Kauffman, Ayelet Shai, Gil Bar-Sela, David Meiri
Publikováno v:
Frontiers in Pain Research, Vol 3 (2022)
The use of medical cannabis (MC) to treat cancer-related symptoms is rising. However, there is a lack of long-term trials to assess the benefits and safety of MC treatment in this population. In this work, we followed up prospectively and longitudina
Externí odkaz:
https://doaj.org/article/0e62212239e74aa79ad8acd7045b712e
Autor:
Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Anton Uribayev, Shiri Procaccia, Idan Cohen, Anca Leibovici, Mahmud Abo-Amna, Luiza Akria, Dmitry Goncharov, Neomi Mativ, Avia Kauffman, Ayelet Shai, Or Hazan, Gil Bar-Sela, David Meiri
Publikováno v:
Pharmaceuticals, Vol 13, Iss 12, p 435 (2020)
In the last decade the use of medical cannabis (MC) for palliative cancer treatment has risen. However, the choice between products is arbitrary and most patients are using Tetrahydrocannabinol (THC)-dominant cannabis products. In this study, we aime
Externí odkaz:
https://doaj.org/article/d74e246789a745cbb048bc92c942b028
Autor:
Dmitry Goncharov, Anca Leibovici, Shiri Procaccia, Mahmud Abo-Amna, Gil Bar-Sela, Joshua Aviram, David Meiri, Or Hazan, Ayelet Shai, Anton Uribayev, Idan Cohen, Gil M. Lewitus, Luiza Akria, Neomi Mativ, Yelena Vysotski, Avia Kauffman
Publikováno v:
Pharmaceuticals
Volume 13
Issue 12
Pharmaceuticals, Vol 13, Iss 435, p 435 (2020)
Volume 13
Issue 12
Pharmaceuticals, Vol 13, Iss 435, p 435 (2020)
In the last decade the use of medical cannabis (MC) for palliative cancer treatment has risen. However, the choice between products is arbitrary and most patients are using Tetrahydrocannabinol (THC)-dominant cannabis products. In this study, we aime